Premier, Inc.PINC

時価総額
$23.3億
PER
医療向けテクノロジー改善サービスの最大手。統合データ分析、SaaS型臨床インテリジェンス、グループ購買とプロキュア・トゥ・ペイを展開。2025年6月13日にIllumiCareを約4,750万ドルで買収。米国全域で約2,700名の従業員と展開。
2014年
6月30日
2015年
6月30日
2016年
6月30日
2017年
6月30日
2018年
6月30日
2019年
6月30日
2020年
6月30日
2021年
6月30日
2022年
6月30日
2023年
6月30日
2024年
6月30日
2025年
6月30日
Net income33323523544925828429230526817510731
Net (loss) income from discontinued operations, net of tax------511-----42
Depreciation and amortization405484107127140153121129134129118
Equity in net (income) loss of unconsolidated affiliates172122151613212416-012
Deferred income taxes101826---69-845771-12327
Stock-based compensation192849262929213546142323
Impairment of assets--------1957140144
Other, net-------1-9-6-7523
Accounts receivable----------11-3
Contract assets-----37852474139-18
Prepaid expenses and other assets----------6-17
Accounts payable----------9-3
Revenue share obligations----------3155
Increase (Decrease) in Accrued Liabilities-----22-30134-71-2045-22
Net cash provided by operating activities from continuing operations-----512340407444--418
Cash Provided by (Used in) Operating Activity, Discontinued Operation------710-----16
Net cash provided by operating activities368364371392508505350407444445297401
Purchases of property and equipment567177719393948987828183
Proceeds from sale of assets-----234----20
Acquisition of businesses, net of cash acquired-----511228426188-40
Sale of investment in unconsolidated affiliates38---------13-
Other--0-0--0-01102--
Net cash used in investing activities-397-232-160-465-93-129-222-175-139-274-68-102
Payments on notes payable91258125199101101103
Proceeds from credit facility61---------435
Payments on credit facility6015----350225250405215155
Proceeds from sale of future revenues----------68142
Payments on liability related to the sale of future revenues----------3253
Cash dividends paid-------93961009577
Repurchase of Class A common stock---123--150-250-400400
Payments on deferred consideration related to acquisition of business----17--29292827-
Payments on earn-out liabilities-----------23
Other, net-------0414-9-4-7
Net cash used in financing activities-38-117-110-19-419-387-169-203-348-167-193-341
Effect of exchange rate changes on cash flows---------0-0-0-0
Net (decrease) increase in cash and cash equivalents------11-4230-43435-41